US FDA removes boxed warning on LABA+ ICS combination for asthma and COPD


eMediNexus    22 December 2017

In an updated drug safety communication released on December 20, 2017, the US FDA has removed the Boxed Warning about asthma-related death from the drug labels of medicines that contain long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS).

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.